We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Expression Analysis to Host Monthly Webinar Series
Product News

Expression Analysis to Host Monthly Webinar Series

Expression Analysis to Host Monthly Webinar Series
Product News

Expression Analysis to Host Monthly Webinar Series


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Expression Analysis to Host Monthly Webinar Series"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EA, has announced that they will host a series of webinars to help researchers gain insight into emerging DNA sequencing applications - “Best Practices for Emerging Applications in DNA Sequencing.”

The series will kick-off on August 17th at 1:00 EST. Webinar participation is free and open to all but advanced registration is required: www.expressionanalysis.com/webinars.

The August webinar will focus on optimization of mRNA sequencing relevant to current microarray platforms. Presenting the program will be Joel Parker, Ph.D, Principal Scientist at EA.

Dr. Parker has been with EA for the past four years and is a recognized leader in bioinformatics with over 70 scientific publications and more than 9900 citations.

Dr. Parker will share data comparing the performance of various mRNA-Seq strategies to microarrays in a breast cancer cell line dataset.

The second in the series is scheduled for September 21st at 1:00 PM EST and will focus on data generated on the PacBio RS platform.

EA was the first commercial service provider to receive and begin offering services on the Pacbio and because of their deep expertise working with new and emerging genomic technologies, EA was chosen to be PacBio’s recommended commercial partner for providing sequencing services to the drug discovery and development market.
Advertisement